Anavex Life Sciences Corp (AVXL)

[plexrec]

New drug licensed to Biogen...and the FDA talking about their commitment and getting drugs to market quicker for needy patients------The FDA used the approval as an opportunity to talk about its commitment to speeding drugs to needy patients to market -- a commitment congressional Republicans have emphasized and that is likely to become more important in a Trump administration. The FDA helped design the Spinraza study, and then told Biogen to analyze the data for 82 patients early even though the study was going to include 121 patients.